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The Esx and PE/PPE families of proteins are among the most immunodominant
mycobacterial antigens and have thus been the focus of research to develop vaccines
and immunological tests for diagnosis of bovine and human tuberculosis, mainly
caused by Mycobacterium bovis and Mycobacterium tuberculosis, respectively. In
non-tuberculous mycobacteria (NTM), multiple copies of genes encoding homologous
proteins havemainly been identified in pathogenic Mycobacterium species phylogenically
related toMycobacterium tuberculosis andMycobacterium bovis. Only ancestral copies
of these genes have been identified in nonpathogenic NTM species like Mycobacterium
smegmatis, Mycobacterium sp. KMS,Mycobacterium sp. MCS, andMycobacterium sp.
JLS. In this study we elucidated the genomes of four nonpathogenic NTM species, viz
Mycobacterium komanii sp. nov., Mycobacterium malmesburii sp. nov., Mycobacterium
nonchromogenicum, and Mycobacterium fortuitum ATCC 6841. These genomes were
investigated for genes encoding for the Esx and PE/PPE (situated in the esx cluster)
family of proteins as well as adjacent genes situated in the ESX-1 to ESX-5 regions. To
identify proteins actually expressed, comparative proteomic analyses of purified protein
derivatives from three of the NTM as well as Mycobacterium kansasii ATCC 12478 and
the commercially available purified protein derivatives from Mycobacterium bovis and
Mycobacterium avium was performed. The genomic analysis revealed the occurrence in
each of the four NTM, orthologs of the genes encoding for the Esx family, the PE and
PPE family proteins in M. bovis and M. tuberculosis. The identification of genes of the
ESX-1, ESX-3, and ESX-4 region including esxA, esxB, ppe68, pe5, and pe35 adds to
earlier reports of these genes in nonpathogenic NTM likeM. smegmatis, Mycobacterium
sp. JLS and Mycobacterium KMS. This report is also the first to identify esxN gene
situated within the ESX-5 locus in M. nonchromogenicum. Our proteomics analysis
Gcebe et al. Genomics and Proteomics of Four NTM
identified a total of 609 proteins in the six PPDs and 22 of these were identified as shared
between PPD of M.bovis and one or more of the NTM PPDs. Previously characterized
M tuberculosis/M. bovis homologous immunogenic proteins detected in one or more
of the nonpathogenic NTM in this study included CFP-10 (detected in M. malmesburii
sp. nov. PPD), GroES (detected in all NTM PPDs but M. malmesburii sp. nov.), DnaK
(detected in all NTM PPDs), and GroEL (detected in all NTM PPDs). This study confirms
reports that the ESX-1, ESX-3, and ESX-4 regions are ancestral regions and thus found
in the genomes of most mycobacteria. Identification of NTM homologs of immunogenic
proteins warrants further investigation of their ability to cause cross-reactive immune
responses with MTBC antigens.
Keywords: non-tuberculous mycobacteria, Esx family, PE/PPE, M. fortuitum, M. malmesburii sp. nov.,M. komanii
sp. nov., M. nonchromogenicum
INTRODUCTION
Purified protein derivatives (PPDs) also known as tuberculins
have been used for more than 100 years as antigens in the
diagnosis of human and bovine tuberculosis (TB), based on
the delayed hypersensitivity (skin) reaction they induce. The
first preparation of PPD was introduced by Robert Koch in
1890, where a boiled crude extract of Mycobacterium containing
a mixture of proteins, both somatic and antigenic, referred
to as “old tuberculin,” was prepared as a potential vaccine
against tuberculosis in humans.Whilst the “old tuberculin” failed
to live up to its initial claim of having curative properties,
it formed the foundation for the modern PPD preparations
(Burke, 1993). Tuberculin based tests (tuberculin skin test
and the interferon gamma assay) have since been used as
diagnostic tools for bovine tuberculosis. While these tests
generally show satisfactory sensitivities, the major drawback to
the tuberculin based assays is the reduced specificity. This is
presumably associated with cross-reactive immune responses
due to exposure of animals and humans to non-tuberculous
mycobacteria (NTM) or environmental mycobacteria and the TB
vaccine strain, Bacille Calmette et Guérin (BCG). These cross-
reactive immune responses are most likely due to the presence
of immunogenic proteins conserved across the Mycobacterium
genus as major components of PPD derived from M. bovis
(Schiller et al., 2010). PPD prepared from Mycobacterium avium
is included as a control antigen representative of the background
responses to environmental mycobacterial antigens in the single
intradermal comparative cervical tuberculin test (SICCT) as well
as the interferon gamma assays used in different countries in
bovine tuberculosis (BTB) control strategies (Vordermeier et al.,
2006). As an alternative approach to mitigate the frequency of
false positive responses to PPD-B induced by environmental
mycobacterial antigens a PPD derived from Mycobacterium
fortuitum (PPD-F) used in the modified BOVIGAM assay, has
shown to increase the test specificity in South Africa (Michel
et al., 2011).
Interference of NTM and BCG in immune responsiveness
against bacteria of the Mycobacterium tuberculosis complex
(MTBC) has triggered investigation of “specific” or defined
antigens which are uniquely present in pathogenic mycobacteria,
and absent in most NTM as well as M. bovis BCG as markers
for the diagnosis of bovine and human tuberculosis (Schiller
et al., 2010). Comparative genomics studies have led to the
identification and characterization of certain genetic regions in
the genomes of mycobacteria that are present in Mycobacterium
tuberculosis and Mycobacterium bovis but absent in M. bovis
BCG and most NTM. The Region of Difference 1 (RD1), a
major deleted region in BCG first described by Mahairas et al.
(1996) seems to have been the early event in the attenuation of
the present vaccine strain, hence proteins within this region are
studied extensively in order to try to understand the virulence of
pathogenic MTBC. The twomost predominant proteins encoded
in the RD1 region, namely the 6 kDa early secreted antigenic
target (ESAT-6/EsxA) and the 10 kDa culture filtrate protein
(CFP-10/EsxB) have been investigated widely for inclusion into
candidate vaccines and used as antigens in the diagnosis of both
TB and BTB (Pym et al., 2003; Vordermeier et al., 2006; Ganguly
et al., 2008). Functional studies have revealed that RD1 encodes
a specialized system for secretion in mycobacteria, involving
genes situated both inside the RD1 locus and its flanking regions,
known as the ESAT-6 secretion system (Brodin et al., 2004).
The ESAT-6 and CFP-10 proteins belong to the Esx family
that consists of 23 small secreted proteins encoded by genes
esxA-esxW and arranged in 11 gene pairs (Bitter et al., 2009).
Five of the 11 genomic pairs are contained in five loci: ESX-
1 to ESX-5 encoding components of the type VII secretion
system (Uplekar et al., 2011). Four of the five loci, except
ESX-4, also harbor 11 proteins of the Proline Glutamate (PE),
or Proline Proline Glutamate (PPE) family, several of which
have been implicated in immune evasion (Akhter et al., 2012;
Mustafa, 2014). The PE and PPE and Esx proteins whose genes
are adjacent to each other in the genome of Mycobacterium
tuberculosis interact to form pairs which appear to be essential
for their secretion (Renshaw et al., 2005). The secretory proteins
have been the focus of research aimed at development of
TB vaccines and immunodiagnostic assays, because they are
thought to have a potential to induce protective immunity and
immune responses of diagnostic value (Ize and Palmer, 2006;
Ganguly et al., 2008; Marongui et al., 2013; Mustafa, 2014).
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Studies have shown however, that some genes encoding for
proteins of the Esx family, as well as PE/PPE do occur in
pathogenic NTM like Mycobacterium kansasii Mycobacterium
marinum, Mycobacterium szulgai, Mycobacterium gordonae,
Mycobacterium gastri, Mycobacterium ulcerans, Mycobacterium
sp. JDM601, and Mycobacterium riyadhense, as well as in
Mycobacterium leprae (Gey van Pittius et al., 2001, 2006; Geluk
et al., 2002, 2004; Newton-Foot et al., 2016) while genes
encoding for PE/PPE family of proteins were also identified in
Mycobacterium abscessus and Mycobacterium avium (Sorensen
et al., 1995; Vordermeier et al., 2007; van Ingen et al., 2009;
Mustafa, 2014). The immunogenicity and cross-reactivity against
MTBC antigens of the ESAT-6 and CFP 10 proteins of pathogenic
NTM was as well-demonstrated in M. kansasii (Waters et al.,
2010). Therefore use of these antigens in BTB diagnosis may be
hampered by the exposure of humans and animals to pathogenic
NTM leading to false positive BTB immunological test results.
Comparative genomic studies of rapidly growing
mycobacteria (RGM) have shown that, contrary to the genomes
of pathogenic MTBC and other pathogenic slow-growing NTM
like M. kansasii and M. marinum which contain the five ESX
regions (ESX-1 to ESX-5), the nonpathogenic RGM such as
Mycobacterium flavescens, M. sp. JLS, M. sp. MCS, M. sp.
KMS, Mycobacterium phlei, Mycobacterium thermoresistible,
Mycobacterium gilvum PYR-GCK, Mycobacterium vaccae,
Mycobacterium vanbaalenii, and M. smegmatis genomes only
harbor ESX-1, ESX-3, and ESX-4 (Gey van Pittius et al., 2006;
Newton-Foot et al., 2016). It was therefore hypothesized that the
three regions (ESX-1, ESX-3, and ESX-4) are genetic factors of
all mycobacteria and ESX-2 and ESX-5 are probably absent in all
RGM (Gey van Pittius et al., 2006).
To assess the presence of homologous proteins in NTM
potentially able to elicit cross-reactive immune responses against
MTBC antigens we elucidated the genomes of four NTM
species, viz Mycobacterium nonchromogenicum, Mycobacterium
fortuitum ATCC 6841, Mycobacterium malmesburii sp. nov.,
and Mycobacterium komanii sp. nov. and compared these
with the genomes of Mycobacterium tuberculosis H37Rv and
Mycobacterium bovis AF2122/97 to identify orthologous genes
situated in the ESX-1 to ESX-5. In addition, the proteomes
of PPDs derived from the NTM viz M. nonchromogenicum
(PPD-N), M. fortuitum ATCC 6841 (PPD-F), M. malmesburii
sp. nov (PPD-M), and M. kansasii ATCC 12478 (PPD-K) were
defined to identify the proteins actually produced and compared
to those of the commercially available PPDs derived from M.
avium and M. bovis. This is the first report of the occurrence of
selected genes encoding proteins that were previously shown to
be immunogenic in M. bovis/M. tuberculosis in the four NTM
genomes as well as the expression of proteins they code for.
MATERIALS AND METHODS
Bacterial Cultures
M. malmesburii sp. nov. and M. komanii sp. nov. were isolated
from cattle nasal swabs during an NTM survey in South Africa
(Gcebe et al., 2013). These two species were previously identified
and characterized as novel NTM (Gcebe et al., unpublished). The
M. nonchromogenicum strain was isolated from soil during an
NTM survey (Gcebe et al., 2013). M. fortuitum ATCC 6841 and
M. kansasii ATCC 12478 were obtained from the Agricultural
Research Council-Onderstepoort Veterinary Institute, South
Africa. The identity of all the strains used was confirmed by
PCR-sequencing assays targeting the 16S rDNA (Gcebe et al.,
2013), hsp65 (Telenti et al., 1993), rpoB (Adékambi et al.,
2006), and sodA (Adékambi and Drancourt, 2004). For PPD
production, liquid cultures were prepared in Middlebrook 7H9
medium (Becton Dickinson, USA) supplemented with 0.1%
OADC and glycerol, incubated under continued shaking at 200
g at 37◦C (optimum growth temperature) for 4 weeks for the
rapid growing mycobacteria (M. fortuitum and M. malmesburii
sp. nov.) and 6 weeks for the slow growing NTM (M. kansasii
andM. nonchromogenicum) or until turbid growth was observed.
The liquid cultures were screened for contaminants before PPDs
were prepared by spread plating each culture on two nutrient agar
plates. The plates were incubated at 25 and 37◦C respectively, and
evaluated after 2 and 5 days for fungal or any bacterial growth not
typical of mycobacteria.
Whole Genome Sequencing, Assembly,
and Annotation
DNA was extracted from bacterial cultures (M. fortuitum, M.
nonchromogenicum, M. komanii sp. nov., and M. malmesburii
sp. nov.) in Löwenstein -Jensen medium (Becton Dickinson,
USA) using the Qiagen nucleic acid extraction kit (Whitehead
Scientific, South Africa). Genomic DNA paired-end libraries
were generated using the Nextera DNA sample preparation kit
(Illumina) and indexed using the Nextera index kit (Illumina).
Sequencing was performed as paired-end reads (2 × 250
bp) employing the Illumina Miseq system using the Miseq
reagent kit v2 at the Agricultural Research Council, as per
manufacturer’s instructions. De novo assembly of the sequencing
reads was performed using SPAdes, which mainly involves
construction of DNA sequences of contigs and the mapping
of reads to contigs (Bankevich et al., 2012). Each assembly
was evaluated using QUAST (Gurevich et al., 2013). The
assembled genome sequences were annotated using Prokka
annotation pipeline (Seemann, 2014). This involved predicting
tRNA, rRNA, and mRNA genes in the sequences and assigning
putative gene products to the protein-coding genes (CDSs)
based on their similarity to sequences in a database of curated
Mycobacterium genes. To gauge the similarity of the NTM
genomes to those of M. bovis AF2122/97 (NC 002945.3) and
M. tuberculosis H37Rv (NC 000962.2), alignment of each of
the processed sets of reads to these reference genomes was
performed using Burrow’s Wheeler Aligner (BWA) (Li and
Durbin, 2009). BLAST Ring Image Generator (Alikhan et al.,
2011) was used to visualize the pairwise BLAST results of
CDS features in M. bovis and each NTM annotation against
that of M. tuberculosis and against the respective closest NTM
relative.
Investigating the Closest Sequence
Relatives of the NTM Strains
Basic local Alignment Search tool (BLAST) search of the
largest contigs from each NTM assembly was performed
against the NCBI Genbank database (http://www.ncbi.nlm.nih.
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gov/genbank/) to identify the closest known sequence relative
of each NTM species. BLAST searches were also performed for
the annotation CDS features for each NTM species against the
reference genomes for their respective best hits and visualized
using BLAST Ring Image Generator (BRIG) (Alikhan et al.,
2011).
TABLE 1 | List of target genes within ESX-1 to ESX-5 loci of M. bovis and M. tuberculosis.
Name/Gene ID Species RefSeq/Genbank Locus Tag Protein product
esxA M.tb WP_000339993.1 Rv3875 6 kDa early secretory antigenic target (ESAT-6)
M. bovis Mb3905 6 kDa early secretory antigenic target (ESAT-6)
esxB M. tb WP_003399940.1 Rv3874 10 kDa culture filtrate antigen LHP (CFP10)
M. bovis Mb3904 10 kDa culture filtrate antigen LHP (CFP10)
esxC M.tb WP_003899750 Rv3890c ESAT-6 like protein EsxC (ESAT-6 like protein 11)
M. bovis Mb3919c Putative esat-6 like protein 11
esxD M.tb WP_003400035.1 Rv3891C Possible esat-6 like protein EsxD
M. bovis Mb3920C Conserved hypothetical protein
esxG M.tb WP_003401503.1 Rv0287 ESAT-6 like protein EsxG
M. bovis Mb0295 Hypothetical protein
esxH M. tb WP_003401514.1 Rv0288 ESAT-6 like protein EsxH
M. bovis Mb0296 low molecular weight protein antigen 7 CFP7 (TB10.4)
esxT M. tb WP_003900059.1 Rv3444C ESAT-6 like protein EsxT
M. bovis Mb3474C Hypothetical protein
esxU M. tb WP_003900060.1 Rv3445C ESAT-6 like protein EsxU
M. bovis Mb3475C Hypothetical protein
esxN M. tb WP_003408840 Rv1793 ESAT-6 like protein EsxN
M. bovis Mb1821 ESAT-6 like protein 5
pe35 M. tb WP_003912361.1 Rv3872 PE family protein
M. bovis Mb3902 PE family- like protein
ppe68 M. tb WP_003399879.1 Rv3873 PPE family protein
M. bovis Mb3903 PPE family protein
pe5 M. tb WP_003401485.1 Rv0285 PE family protein
M. bovis NP_853957.1 Mb0293 PE family protein
ppe4 M. tb WP _003401488.1 Rv0286 PPE family protein
M. bovis Mb0293 PPE family protein
ppe25 M. tb WP_003901254.1 Rv1787 PPE family protein
M. bovis Mb1815 PPE family protein
pe18 M.tb WP_003408976.1 Rv1788 PE family protein
M. bovis Mb1816 PE family protein
ppe26 M. tb WP_003408979.1 Rv1789 PPE family protein
M. bovis Mb1817 PPE family protein
ppe27 M. tb WP_003408805.1 Rv1790 PPE family protein PPE27
M. bovis Mb1818 PPE family protein
pe19 M. tb WP_003408807.1 Rv1791 PE family protein
M. bovis Mb1819 PE family protein
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Identification of Predicted Immunogenic
Proteins in NTM Genomic Annotations
BLAST searches were conducted to quantify the similarity of
the annotated amino acid sequences in the NTM assemblies (M.
fortuitum, M. malmesburii sp. nov., M. komanii sp. nov., and
M. nonchromogenicum) to immunogenic proteins in M. bovis,
M. tuberculosis, and M. smegmatis. Esx family proteins, PE
and PPE proteins situated within the ESX-1 to ESX-5 clusters
were chosen for this investigation (see Table 1 for the complete
list of targeted proteins). BLASTP searches against the NCBI
Genbank database were also conducted for the respective NTM
protein sequences to quantify similarity to other sequences
in the database. Multiple amino acid sequence alignments of
the individual proteins: (Esx, PE, PPE situated in ESX-1 and
ESX-3) and from different mycobacteria were performed using
Clustalw (Thompson et al., 1994) from MEGA (version 6), to
assess sequence similarities of the M. bovis/M. tuberculosis and
the NTM orthologs at immunogenic epitope level. Amino acid
and nucleotide sequences from M. bovis and M. tuberculosis
were retrieved from Genolist (http://genolist.pasteur.fr) and
those of M. smegmatis were retrieved from Smegmalist (http://
mycobrowser.epfl.ch/smegmalist.html) databases. NTM protein
orthologs that showed amino acid sequence similarities of <50%
to the respective M. bovis antigen were not included in the
alignments. To confirm orthology of the esx gene clusters present
in NTM in this study (ESX-1, ESX-3, and ESX-4 as well as
ESX-2 of M. nonchromogenicum) to the MBTC (http://genolist.
pasteur.fr) and M. smegmatis MC2155 (http://mycobrowser.epfl.
ch/smegmalist.html) ESAT-6 regions the four NTM genomes
were also assessed for the genes adjacent to the esx and pe/ppe.
The genomic organization of the ESX-1, ESX-3, and ESX-4 of
the NTM including ESX-2 of M. nonchromogenicum was also
evaluated.
TABLE 2 | Data acquisition.
FULL SCAN
Resolution 70,000 (@ m/z 200)
AGC target value 3e6
Scan range 320–2000 m/z
Maximal injection time (ms) 100
DATA-DEPENDENT MS/MS
Resolution 17,500 (@ m/z 200)
AGC target value 2e5
Maximal injection time (ms) 50
Isolation window width (Da) 3
NCE (%) 27
DATA-DEPENDENT SETTINGS
Underfill ratio (%) 1
Charge exclusion Charge states 1,6-8,>8
Peptide match preferred
Exclusion isotopes on
Dynamic exclusion (s) 60
PCR Verification of the Presence of Genes
in ESX-1, ESX-3 as well as esxN in NTM
We set out experiments to confirm the presence of ESX-1 in
the four NTM genomes by PCR and sequencing of the two
most investigated genes in this region: esxA and esxB. The
presence of ESX-3 in the four newly sequenced NTM was
verified by amplification of esxH. Since it was previously shown
by hybridization experiments that ESX-5 might be absent in
Mycobacterium nonchromogenicum we verified the presence of
esxN ortholog (situated in ESX-5 locus) inM. nonchromogenicum
by PCR and sequencing.
The primers used for amplification of esxA were
MSMEG_0066 –F (5′-AATTTCGCCGGTATCGAGGG- 3′)
located at position 19–38 bp of the MSMEG_0066 gene (an
M. smegmatis MC2155 esxA ortholog), and MSMEG_0066-R
(5′ CAGGCAAACATTCCCGTGAC 3′) located at position
278–268 bp of the esxA ortholog of M. smegmatis MC2155
(MSMEG_0066).
The primers for amplification of esxB were MSMEG_0065-F
(5′ GCGAATTTCGAGCGCATCTC 3′) situated at position 46–
65 bp, and MSMEG_0065-R (5′ GATGTTCATCGACGACGC
AAG 3′) situated at position 300–280 bp.
Primers used for esxH were esxH-13 (5′- ARGTACAAC
TACCCGGCGATG-3′-) situated at position 13–33 bp of
MSMEG_0621 gene (an M. smegmatis ortholog of esxH),
and esxH-245 (5′-GCCATGGTGTTCTGCTCGT-3′) situated at
position 245–226 bp of MSMEG_0621 gene.
Finally, primers used for amplification of esxN were esxN-
F (5-′ GACGATTAATTACCAGTTCG-3′) situated at position
3–20 bp of the gene in M. tuberculosis, and esxN-R (5′-GGT
TTGCGCCATGTTGT-3′) situated at position 255–239 bp of
the gene.
PCR
Boiled culture suspensions were prepared from colonies as
template for DNA amplification. The following PCR conditions
were used for amplification of each of the three gene fragments:
A 50 µl PCR mixture was prepared, containing 28.5 µl de-
ionized water, 3 µl MgCl2(25mM), 1 µl dNTP mix (10mM),
4.75 µl of 10x PCR buffer (160mM) (Tris -HCl, MgCl2,
Tween 20,(NH4)2,SO4), 0.75 µl Taq DNA Polymerase (5 U/µl)
(Supertherm TM), 1 µl of each forward and reverse primers (50
pmol), and 10 µl of DNA template. The PCR cycling parameters
were as follows: Fourty five cycles of denaturation at 94◦C for 1
min, annealing at 60◦C (55◦C for esxN) for 1 min, and elongation
at 72◦C for 1min and final extension at 72◦C for 10min. The PCR
products were ran on a 1.5% agarose gel and visualized under
ultra violet light (UV).
Sequencing and Sequence Analysis
Sequencing of the PCR products was done at Inqaba
Biotechnologies (Pretoria, South Africa). Sequencing was
performed in both directions using the forward and reverse
primer sequences that were initially used for amplification.
Sequences from both strands were edited manually and pairwise
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alignments undertaken using the BioEdit Sequence alignment
editor (version 7.1.9) and Molecular Evolutionary Genetics
Analysis (MEGA) platform (http://www.megasoftware.net)
(version 6) (Tamura et al., 2013). The resulting consensus
sequences were analyzed on the NCBI platform for gene
sequence identity/similarity using BLAST (http://blast.ncbi.nlm.
nih.gov/Blast.cgi).
PPD Production
PPDs were prepared from M. nonchromogenicum (PPD- N), M.
malmesburii sp. nov. (PPD-M), M. fortuitum ATCC 6841 (PPD-
F), and M. kansasii ATCC 12478 (PPD-K). Three preparations
of each PPD [one at a different time interval (first preparation)
and two done at the same time (second and third preparations)]
were done following a modified protocol by Landi (1963). Briefly,
liquid cultures were inactivated by steaming at 121◦C for 20 min.
and filter- sterilized using the Whatman 40 filter paper and a
vacuum pump. Each filtrate was then precipitated by adding 40%
trichloroacetic acid (TCA) to a final concentration of 4% v/v)
and left for at least 12 h at 4–8◦C. Afterwards the precipitated
filtrates were mixed manually by shaking and centrifuged at
room temperature for 20 min at 3900 g. The supernatants were
discarded and the pellets washed twice by suspending them in 1%
TCA and careful mixing, followed by centrifugation at 3900 g for
20 min at room temperature. The supernatants were discarded
and the pellets suspended in 10% NaCl, then centrifuged for
20 min at 3900 g. After discarding the supernatant, the pellet was
harvested by turning the tube upside down, on a piece of sterile
filter paper and allowed to dry, weighed, diluted with 0.005%
PPD buffer (0.005% Tween 80 in PBS: PH = 7.38) and stored
at 4–8◦C until peptide digestion. The purified protein derivatives
from M. bovis (PPD-B) and M. avium (PPD-A) were obtained
from Prionics at the Netherlands.
In-Solution Digest of PPDs with Trypsin
(IAA)
Trypsin digestion of each PPD preparation was done at the
Centre for Proteomics and Genomics Research (CPGR, South
Africa). All reagents used were analytical grade or equivalent.
Twenty microgram of protein was dissolved in 10 µl of 50
mM triethylammonium bicarbonate (TEAB; Sigma). Protein
was reduced by adding 1 µl of 100 mM tris (2-carboxyethyl)
phosphine (Sigma) prepared in 50 mM TEAB, and incubated
at 60◦C for 1 h. Samples were cooled to room temperature
and the protein was alkylated by adding 1 µl of 200 mM
iodoacetamide (Sigma) prepared in 50 mM TEAB. Samples
were incubated at room temperature in the dark for 30
min. The sample volume was adjusted to 50 µl with 50
mM TEAB and then 5 µl of 1 µg/µl trypsin (Promega),
prepared in MilliPore water, was added and digestion was
allowed to take place at 37◦C for 18 h, followed by vacuum
centrifugation.
TABLE 3 | Summary of the de novo assembly results.
NTM Species Strain ID number of contigs (n) Largest contig (bp) Total Length (bp) L50 N50
M. fortuitum ATCC 6841 179 195 004 6 275 573 27 82 193
M. nonchromogenicum NCK 8460 642 425 774 6 623 407 17 131 682
M. malmesburii sp. nov. WCM 7299 255 135 683 5 426 606 42 42 651
M. komanii sp. nov. GPK 1020 63 298 570 5 370 343 12 162 386
TABLE 4 | Annotation of the assembled genome, showing number of CDS, tRNA, rRNA, and signal peptides.
NTM species Strain ID CDS tRNA rRNA Signal peptides
M. fortuitum ATCC 6841 6097 66 3 499
M. nonchromogenicum NCK 8460 6903 70 3 544
M. malmesburii sp. nov. WCM 7299 5298 54 2 401
M. komanii sp. nov. GPK 1020 5141 53 2 408
NTM, non-tuberculous mycobacterium, CDS, coding sequences.
TABLE 5 | BLAST results using the largest contig of each NTM against Genbank nucleotide database (E < 1 × 106).
NTM species Species hit BLAST score Query coverage (%) Identity (%)
M. fortuitum M. smegmatis MC2 155 11121 65 81
M. nonchromogenicum M. smegmatis MC2 155 8822 69 83
M. malmesburii sp. nov. M. rhodesiae NBB3 8503 52 81
M. komanii sp. nov. Mycobacterium sp.JLS 5565 45 81
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Mass Spectrometry
LC–MS/MS Analysis
LC-MS/MS analysis was conducted in triplicate for NTM PPDs
from the second and the third preparations and once for the
first preparation and the commercial PPDs (PPD from M. bovis
and from M. avium) using a Q-Exactive quadrupole-Orbitrap
mass spectrometer (Thermo Fisher Scientific, USA) coupled
with a Dionex Ultimate 3000 nano-HPLC system at CPGR. The
mobile phases consisted of solvent A (0.1% formic acid in water)
and solvent B (80% ACN, 10% water, and 0.1% formic acid).
The peptides (as an estimate 500 ng for each sample) were re-
suspended in sample loading buffer (95% water, 5% Acetonitrile,
0.05% TFA) and loaded on a C18 trap column (100 µm× 20mm
× 5µm). Chromatographic separationwas performedwith a C18
column (75 µm ×1 50mm ×3 µm). The gradient was delivered
at 300 nl/min and consisted of a linear gradient of mobile phase
B initiating from solvent B, 6–60% over 156 min. The mass
spectrometer was operated in positive ion mode with a capillary
temperature of 250◦C. The applied electrospray voltage was 1.95
kV. Details of data acquisition are listed in Table 2.
LC-MS/MS Data Analysis
Database Searching
All MS/MS samples were analyzed using Mascot (Matrix
Science, London, UK; version 2.4.1) and X! Tandem (The
GPM, thegpm.org; version CYCLONE (2010.12.01.1). Mascot
was set up to search the Mycobacterium database (derived from
UniProtKB, 843597 entries) assuming the digestion enzyme
trypsin. X! Tandem was set up to search a subset of the
Mycobacterium database including also assuming trypsin.Mascot
and X! Tandem were searched with a fragment ion mass
tolerance of 0.020 Da and a parent ion tolerance of 10.0 PPM.
Carbamidomethyl of cysteine were specified in Mascot and
X! Tandem as fixed modifications. Gln->pyro-Glu of the n-
terminus, deamidation of asparagine and glutamine, oxidation
of methionine were specified in Mascot and X! Tandem variable
modifications.
Criteria for Protein Identification
Scaffold (version Scaffold_4.3.4, Proteome Software Inc.,
Portland, OR) was used to validate MS/MS based peptide and
protein identifications. Peptide identifications were accepted
if they could be established at greater than 9.0% probability
to achieve an FDR less than 0.1% by the Scaffold Local FDR
algorithm (Keller et al., 2002). Protein identifications were
accepted if they could be established at >100.0% probability
to achieve an FDR less than 1.0% and contained at least four
identified peptides (Keller et al., 2002). Protein probabilities were
assigned by the Protein Prophet algorithm (Nesvizhskii et al.,
2003). Proteins that contained similar peptides and could not be
differentiated based on MS/MS analysis alone were grouped to
satisfy the principles of parsimony.
FIGURE 1 | Alignment ofM. bovis and NTM predicted CDS regions to those ofM. tuberculosis visualized using BRIG. Immunogenic proteins of interest are
highlighted in red (also see Table 1).
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RESULTS
Alignment of the Four NTM Sequence
Reads with the Genomes of M. bovis and
M. tuberculosis
Alignment of the NTM reads (DNA sequences) and the reference
genomes [M. bovis (NC 002945.3) and M. tuberculosis (NC
000962.3)] showed very little similarity between the NTM
genomes and each of the reference strains. M. komanii sp.
nov. genome seems to be the closest of the NTM to the
reference genomes (18.61 and 18.69% of the sequence reads
maps to M. bovis and M. tuberculosis genomes, respectively),
followed by M. nonchromogenicum (15.71 and 15.8%), and
M. fortuitum (10.58 and 10.63%). M. malmesburii sp. nov.
showed the least similarity of its genome to that of the
reference strains (8.83 and 8.89%). The GC contents of the
NTM genomes were 66.19% for M. fortuitum, 66.25% for M.
nonchromogenicum, 67.4% for M. malmesburii sp. nov., and
67.33% for M. komanii sp. nov., which is as high as the GC
contents ofM. tuberculosis andM. bovis (both have GC contents
of 66.5%).
De novo Assembly of the NTM DNA
Sequence Reads
The result for the assembly of the DNA sequence reads is
summarized in Table 3. The number of contigs, the length of
the largest contig as well as the N50 (the length for which the
set of contigs of that length or longer contains at least half the
assembly bases) and L50 (the number of contigs of that length
for each assembly is presented). The overwhelming majority of
the sequenced bases fall within the few largest contigs, but each
assembly also produced a large number of very short contigs.
The assembly for M. komanii sp. nov. produced 63 contigs, with
its largest contig 292, 570 bases in size. While the assembly
for M. nonchromogenicum produced the largest contig of all
(425, 774 bases), it also produced the highest number of contigs
(642 bases). The M. fortuitum and M. malmesburii sp. nov
assemblies provided high total numbers of contigs (179 and 255
respectively), their largest contigs were 195, 004 and 135, 683
bases respectively.
Annotation of the Assembled Genome
The summary of the annotation is provided in Table 4. The
numbers of protein coding genes, sequences encoding tRNA
FIGURE 2 | Alignment of M. fortuitum predicted CDS regions to those of M. smegmatis MC2 155 (CP001663.1) using BRIG. Immunogenic proteins of
interest identified in M. smegmatis are highlighted in red (esxB: locus tag MSMEG_0065, product hypothetical protein; esxA: locus tagMSMEG_0066, product early
secretory antigenic target, 6 kDa; dnaK: locus tag MSMEG_0709, product of chaperone protein DnaK; mpt63: locus tag MSMEG_0828, product immunogenic
protein MPT63; mpt64: locus tagMSMEG_2331, product immunogenic protein MPB64/MPT64; mpt70: locus tag MSMEG_5196, product fasciclin domain-containing
protein; canA: locus tag MSMEG_4985, product carbonic anhydrase; tpx: locus tagMSMEG_3479, product thiol peroxidase).
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and rRNA and signal peptides identified in each of the four
NTM genomes are indicated. The annotated assemblies were
deposited into the European Nucleotide Archive (ENA)
database (http://www.ebi.ac.uk/ena). The sequence identifiers
i.e., locus tag and the accession numbers are BN1849 and
CVRX01000001-CVRX01000338, respectively for M. fortuitum;
BN1848 and CVTC01000001-CVTC01002268, respectively
for M. nonchromogenicum; BN1837 and CVTB01000001-
CVTB01000324, respectively for M. malmesburii sp. nov.; and
finally BN1838 and CVTA01000001-CVTA0100065, respectively
forM. komanii sp. nov.
Closest Sequence Relatives of the Four
NTM Genomes (M. malmesburii sp. nov.,M.
komanii sp. nov., M. nonchromogenicum,
and M. fortuitum ATCC 6841)
Table 5 represents the BLAST results for each NTM’s largest
contig. Mycobacterium fortuitum and to a lesser extent
M. nonchromogenicum have the closest resemblance to
M. smegmatis MC2 155 (accession number CP001663.1) with
M. malmesburii sp. nov. displaying similarity to M. rhodesiae
(CP003169.1). M. komanii sp. nov. seems to be the most novel
organism scoring its highest BLAST score with Mycobacterium.
sp. JLS (CP000580.1).
Genome Assembly Visualization by
Alignment to Reference Genomes (i.e., M.
rhodesiae, M. smegmatis MC2155, M.
tuberculosis H37Rv, and Mycobacterium.
sp. JLS)
Visualization of the alignment of the M. bovis and the
predicted CDS regions of the four NTM species, i.e.,
M. nonchromogenicum,M. malmesburii sp. nov.,M. komanii sp.
nov., and M. fortuitum to those of M. tuberculosis H37Rv using
BLAST Ring Image Generator (BRIG) is given in Figure 1, while
alignment of each NTM predicted CDS to their closest relatives is
FIGURE 3 | Alignment of M. nonchromogenicum predicted CDS regions to those of M. smegmatis MC2 155 (CP001663.1) using BRIG. Immunogenic
proteins of interest identified in M. smegmatis are highlighted in red (esxB: locus tag MSMEG_0065, product hypothetical protein; esxA: locus tagMSMEG_0066,
product early secretory antigenic target, 6 kDa; dnaK: locus tag MSMEG_0709, product of chaperone protein DnaK; mpt63: locus tag MSMEG_0828, product
immunogenic protein MPT63; mpt64: locus tagMSMEG_2331, product immunogenic protein MPB64/MPT64; mpt70: locus tag MSMEG_5196, product fasciclin
domain-containing protein; canA: locus tag MSMEG_4985, product carbonic anhydrase; tpx: locus tagMSMEG_3479, product thiol peroxidase).
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shown by the images in Figure 2 (M. fortuitum andM. smegmatis
MC2155), Figure 3 (M. nonchromogenicum and M. smegmatis
MC2155), Figure 4 (M. malmesburii sp. nov. and M. rhodesiae),
and Figure 5 (M. komanii sp. nov. and Mycobacterium sp. JLS).
The positions of the immunogenic proteins of interest in the
reference genomes are also highlighted.
Orthologs of the Esx and PE/PPE Family
Proteins Situated within the ESX-1 to
ESX-5 Regions
The orthologs of the Esx and PE/PPE family proteins (situated
within the ESX-1 to ESX-5 regions) deducted from the newly
sequenced NTM genomes are listed in Table 6. The ESX-1, ESX-
3 and ESX-4 loci were found in all four of the newly annotated
NTM genomes, while the ESX-2 and ESX-5 loci seem to be absent
in three of the NTM genomes (M. fortuitum, M. malmesburii
sp. nov., and M. komanii sp. nov). This is consistent with
what was observed in the genomes of other rapidly growing
NTM likeM. smegmatis, Mycobacterium sp. JLS,Mycobacterium
vanbaalenii, Mycobacterium vaccae, Mycobacterium sp. MCS,
Mycobacterium thermoresistible, Mycobacterium sp. KMS, and
M. flavescens where only three of the ESAT-6 loci (ESX-1, ESX-
3, and ESX-4) were found to be present (Gey van Pittius et al.,
2001, 2006; Newton-Foot et al., 2016). In-order to confirm the
orthology of the NTM esx and pe/ppe genes to those of M.
bovis/M. tuberculosis as well as the potential of their protein
products to be secreted,we also investigated the newly sequenced
NTM genomes for the adjacent genes situated in the ESX loci, as
well as the genomic organization of these loci. The organization
of these genes in the ESX- loci is illustrated in Figure 6. EsxA and
esxB as well as esxG and esxH were found next to each other in the
genomes of the newly sequencedNTM. The pe35 and ppe68 genes
were found to occur next to each other in the genomes of the four
newly sequenced NTM. One member of the pe5/ppe4 pair (ppe4),
was not detected in any of the newly sequencedNTM.Comparing
the ESX loci ofM. tuberculosis andM. bovis to those of the newly
sequenced NTM, we found that, all the genes of the ESX-1 locus
and their organization (as known to occur in M. tuberculosis
and M. bovis) except espJ (whose function is unknown), were
FIGURE 4 | Alignment ofM. malmesburii sp. nov. predicted CDS regions to those ofM. rhodesiae NBB3 (CP003169.1) using BRIG. Immunogenic proteins
of interest identified in M. rhodesiae are highlighted in red (dnaK: locus tagMycrhN_1341, product chaperone protein DnaK; mpt70: locus tag MycrhN_3596, product
secreted/surface protein with fasciclin-like repeats; canA_1: locus tag MycrhN_1479, product sulfate permease-like transporter, MFS superfamily; canA_2: locus tag
MycrhN_2217, product carbonic anhydrase; canA_3: locus tagMycrhN_2307, product isoleucine patch superfamily enzyme, carbonic anhydrase/acetyltransferase;
canA_4: locus tag MycrhN_3599, product isoleucine patch superfamily enzyme, carbonic anhydrase/acetyltransferase; canA_5: locus tag MycrhN_3776, product
carbonic anhydrase. Carbonic anhydrase genes have been numbered according to genomic position).
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FIGURE 5 | Alignment of M. komanii sp. nov. predicted CDS regions to those of M. sp. JLS (CP000580.1) using BRIG. Immunogenic proteins of interest
identified in M. sp. JLS are highlighted in red (esxB: locus tag Mjls_0060,product hypothetical protein; esxA: locus tag Mjls_0061, product 6 kDa early secretory
antigenic targetEsaT6; hsp20: locus tag Mjls_1109, product heat shock protein Hsp20; Mjls_1343: locus tag Mjls_1343, product of polysaccharide biosynthesis
protein; cfp6: locus tag Mjls_1885, product low molecular weight protein antigen 6; cfp2: locus tag Mjls_3145, product low molecular weight antigen; Mjls_5331:
locus tag Mjls_5331,product lipoprotein antigen family protein; dnaK: locus tag Mjls_0449, product molecular chaperone DnaK;mpt64: locus tag Mjls_1842, product
immunogenic protein MPB64/MPT64; mpt70_1: locus tag Mjls_2023,product beta-Ig-H3/fasciclin; mpt70_2: locus tag Mjls_2024, product beta-Ig-H3/fasciclin;
mpt70_3: locus tagMjls_4307, product beta-Ig-H3/fasciclin; Mjls_1176: locus tag Mjls_1176, product peptidase M22, glycoprotease; gcp: locus tag Mjls_1178,
product putative DNA-binding/iron metalloprotein/AP endonuclease; canA_1: locus tag Mjls_3936, product carbonic anhydrase; canA_2: locus tag Mjls_4306,
product carbonic anhydrase;canA_3: locus tag Mjls_5131, product carbonic anhydrase; Mjls_0685: locus tag Mjls_0685, product alkyl hydro peroxide reductase/
Thiol specific antioxidant/ Mal allergen; Mjls_3070: locus tag Mjls_3070, product alkyl hydro peroxide reductase; Mjls_3370: locus tag Mjls_3370, product alkyl hydro
peroxide reductase; Mjls_3657: locus tag Mjls_3657, product alkyl hydro peroxide reductase.
found in all four newly sequenced NTM as shown in Figure 6.
Likewise all the genes of the ESX-3 (except ppe4) and ESX-4
loci (as known to occur in M. tuberculosis and M. bovis) were
also found in all four newly sequenced NTM (Figure 6). The
only NTM species that was found to harbor an Esx ortholog of
the ESX-5 locus (esxN) as well as 4 of the 12 ESX-2 genes was
M. nonchromogenicum.
To quantify amino acid sequence homology of the EsxA
and EsxB of Mycobacterium fortuitum in this study to other
species in the NCBI database we conducted BLASTP searches.
Interestingly, the BLAST searches using the M. fortuitum EsxA
and EsxB amino acid sequences revealed the existence of their
orthologs in additional NTM species, most notably M. vulneris
(98% similarity to M. fortuitum at amino acid level for both
proteins),M. mageritense (82 and 74% similarity toM. fortuitum
respectively, at amino acid level), and M. farcinogenes (96 and
92% similarity toM. fortuitum respectively, at amino acid level).
Verification of the Presence the esx Genes
in the Newly Sequenced NTM
The presence of esxA and esxBwere confirmed inM. fortuitum by
PCR and sequencing using primers designed fromM. smegmatis
sequences followed by BLAST searches. We demonstrated
the presence of both these gene fragments in Mycobacterium
fortuitum ATCC 6841 whose nucleotide sequences were 89 and
85% identical to the M. smegmatis esxA and esxB orthologs.
M. tuberculosis/M. bovis derived primers did not amplify any
of the NTM (results not shown). Likewise the M. smegmatis
derived primers could not amplify these genes in other
NTM (M. nonchromogenicum, M. malmesburii sp. nov., and
M. komanii sp. nov.).
The presence of esxH was also confirmed by PCR and
sequencing in M. fortuitum (74% identical to the M. smegmatis
esxH ortholog); M. komanii sp. nov. (82% identical to the
M. smegmatis ortholog); and finally in M. malmesburii sp.
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nov., (84% identical to the M. smegmatis ortholog). The M.
nonchromogenicum ortholog did not amplify when these primers
were used.
Since DNA-DNA hybridization analysis by Gey van Pittius
et al. (2006) previously suggested that ESX-5 may be absent
in M. nonchromogenicum or the species was evolutionary so
far removed from the slow growers that gene homology was
insufficient to allow hybridization, we set out to verify the
presence of esxN in this species by PCR and sequencing using
primers designed from the esxN/rv1793c gene ofM. tuberculosis.
The highest BLAST hit of the sequenced gene fragment reveals
that this sequence was 91% closely related to Mycobacterium
species JDM601 esxN gene.
Comparison of Amino Acid Sequence of
the M. bovis/M. tuberculosis Immunogenic
Epitopes of ESAT-6, CFP-10, TB10.4,
PPE68, to the NTM Homologs
ESAT-6 (EsxA)
The amino acid sequence alignment of M. fortuitum, M.
nonchromogenicum, M. smegmatis, M. bovis/M. tuberculosis
ESAT-6 homologs is demonstrated in Figure 7. Immunogenic
epitopes (underlined sequences in Figure 7) of M. bovis
ESAT-6 as demonstrated by Vordermeier et al. (2000, 2003,
2007) were found in M. fortuitum, M. nonchromogenicum
as well as in M. smegmatis orthologs. Comparison of M.
bovis, M. nonchromogenicum, M. smegmatis, and M. fortuitum
immunodominant epitopes revealed the following results: amino
acid sequence similarities of 13/16 (81.28%) between the three
NTM andM. bovis for the epitope at position 1-16; 9/17 (52.9%)
and 10/17 (58.8%) amino acid residues were identical betweenM.
smegmatis and M. bovis and between M. nonchromogenicum, M.
fortuitum, and M. bovis respectively, for the epitope at position
16-32, while 12/18 (66%) amino acid sequence identity was
observed between the three NTM and M. bovis for the epitope
at position 47-64; 12/19 (63%) for the epitope at position 56-
74; 15/17 (88%) for the epitope at position 65-81 were identical
between the three NTM and M. bovis. Finally 11/15 identity
betweenM. fortuitum, M. nonchromogenicum, and M. bovis, and
12/15 betweenM. smegmatis andM. bovis for epitope at position
81-95. Amino acid sequence similarities of 90 and 95% for the
ESAT-6 were observed between M. smegmatis and M. fortuitum
as well asM. smegmatis andM. nonchromogenicum, respectively.
CFP-10 (EsxB)
Comparison of amino acid sequences of the CFP-10 homologs
of M. fortuitum, M. nonchromogenicum, M. smegmatis, M.
malmesburii sp. nov, M. komanii sp. nov, M. bovis, and M.
tuberculosis is illustrated by the amino acid alignment in Figure 8
and immunogenic epitopes as demonstrated by Vordermeier
et al. (2003, 2007) are underlined. Comparing the CFP-10 amino
TABLE 6 | Orthologs of the Esx and PE/PPE family proteins in the four NTM genomes.
Locus esx/pe/ppe gene tag Percentage homology of Esx and PE/PPE amino acid sequences deducted from the different NTM to M. bovis
M. komanii sp. nov. M. malmesburii sp. nov M. fortuitum M. nonchromogenicum
ESX-1 esxA/Rv3875/Mb3905 48.75 50 75.79 71.58
esxB/Rv3874/Mb3905 57.73 57.73 64 64
pe35/Rv3872/Mb3902 51.55 51.55 52.22 52.22
ppe68/Rv3873/Mb3903 63.65 47.79 59.44 56.10
ESX-2 esxC/Rv3890c/Mb3919c no no no no
esxD/Rv3891c/Mb3920c no no no no
ppe69/Rv3892c/Mb3921c no no no no
pe36/Rv3893c/Mb3922c no no no no
ESX-3 esxG/Rv0287/Mb0295 78.35 78.35 81.5 81.05
esxH/Rv0288/Mb0296 76 76 75.79 77.94
pe5/Rv0285/Mb0293 72.28 72.28 74.54 74.51
ppe4/Rv0286/Mb0294 no no no no
ESX-4 esxT/Rv3444c/Mb3474c 73.4 73.96 73.96 73.96
esxU/Rv3445c/Mb3475c 60.75 56.01 60.42 60.42
ESX-5 esxM/Rv1792/Mb1820 no no no no
esxN/Rv1793/Mb1821 no no no 85.11
ppe25/Rv1787/Mb1815 no no no no
pe18/Rv1788/Mb1816 no no no no
ppe26/Rv1789/Mb1817 no no no no
ppe27/Rv1790/Mb1818 no no no no
pe19/Rv1791/Mb1819 no no no No
no, no ortholog detected.
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FIGURE 6 | Schematic representation of the genomic arrangement of orthologs of genes present in three ESAT-6 gene cluster regions: ESX-1, ESX-3,
and ESX-4 of M. fortuitum, M. malmesburii sp. nov., M. nonchromogenicum (as well as ESX-2), and M. komanii sp. nov., compared to M. tuberculosis
and M. smegmatis. M. tuberculosis annotation was also used for the NTM orthologs (except for M. smegmatis). Protein coding sequences are represented by
blocked arrows reflecting the relative lengths of the genes and the direction of transcription. Genes of M. tuberculosis are color coded according to the protein families
they encode for (Gey van Pittius et al., 2006). The unannotated genes in NTM encode for hypothetical proteins.
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FIGURE 7 | Alignment of EsxA aa sequences of M. fortuitum ATCC 6841 (M. fortuit), I MC2155 (M. smegmat), M. bovis, and M. tuberculosis (M.
tubercu). *Represents identical sequences observed in all species, and >indicates presence of the same aa residue in at least one of the NTM species. Highly
immunogenic epitopes of M. bovis as described by Vordermeier et al. (2000, 2003, 2007) are underlined.
FIGURE 8 | Alignment of EsxB aa sequences of M. fortuitum ATCC 6841 (M. fortuit), M. smegmatis MC2 155 (M. smegmat), M. malmesburii sp. nov (M.
malmesb), M. komanii sp. nov., M. bovis, and M. tuberculosis (M. tubercu). *Represents identical sequences observed in all species, and >indicates presence
of the same aa residue in at least one of the NTM species. Highly immunogenic epitopes of M. bovis as described by Vordermeier et al. (2000, 2003, 2007) are
underlined.
acid sequences of M. bovis and the NTM orthologs revealed the
following: for the epitope at position 1-19, a total of 14/19 (73.7%)
of the amino acid residues were identical between M. bovis,
M. smegmatis, M. nonchromogenicum, and M. fortuitum, while
only 12/19 (63%) amino acid residues were identical between
M. bovis, M. komanii sp. nov., and M. malmesburii sp. nov.
For the epitope at position 13-28, a total of 11/16 (68.75%)
of the amino acids were found to be identical between M.
smegmatis, M. nonchromogenicum, M. fortuitum, and M. bovis,
while 10/16 (62.5%) were identical betweenM. komanii sp. nov.,
M. malmesburii p. nov., andM. bovis. The epitope at position 28-
44 had 9/16 (56.25%) amino acid residues identical between M.
bovis, M. fortuitum, M. nonchromogenicum, and M. smegmatis,
while 8/16 (50%) were identical between M. bovis, M. komanii
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FIGURE 9 | Alignment of EsxH aa sequences of M. fortuitum ATCC 6841 (M. fortuit), M. smegmatis MC2155 (M. smegmat), M. malmesburii sp. nov. (M.
malmesb), M. komanii sp. nov., M. nonchromogenicum (M. nonchro), M. bovis, and M. tuberculosis (M. tubercu). *Represents identical sequences
observed in all species, and >indicates presence of the same aa residue in at least one of the NTM species. Highly immunogenic epitopes of M. tuberculosis as
described by Skjøt et al. (2002) are underlined.
sp. nov. and M. malmesburii sp. nov. The epitope at positon
55-72 showed sequence identity of 12/16 (75%) of the amino acid
residues betweenM. bovis,M. fortuitum,M. nonchromogenicum,
M. smegmatis, M. komanii sp. nov., and M. malmesburii sp.
nov. For the epitope at position 56-76, 12/20 (60%) of the
amino acids were identical between all five NTM and M. bovis.
Finally, for epitope at position 76-93, 9/18 (50%) of the amino
acid residues were identical between M. bovis, M. fortuitum,
M. nonchromogenicum, and M. smegmatis, while 6/18 (33.3%)
were identical between M. bovis, M. komanii sp. nov., and M.
malmesburii sp. nov.
TB10.4 (EsxH)
Alignment of the EsxH amino acid sequences of the NTM,
M. bovis, and M. tuberculosis species is illustrated in Figure 9
and immunogenic epitopes described by Skjøt et al. (2002)
are underlined. For the epitope at position 11-28, amino acid
sequence similarities of 61% were observed between each EsxH
orthologs of M. komanii sp. nov., M. malmesburii sp. nov., and
M. bovis/M. tuberculosis while M. nonchromogenicum and M.
fortuitum each shared 44.4% similarities with the M. bovis/M.
tuberculosis epitope. For the epitope at position 21-38, 66.7%
identity was observed between each of the two NTM species
(M. komanii sp. nov. and M. malmesburii sp. nov.) and M.
tuberculosis/M. bovis. This epitope was 55.5% identical to M.
fortuitum as well as M. nonchromogenicum sequence. Finally,
for the epitope at position 31-48, 77.7% amino acid sequence
identity was observed between each of M. komanii sp. nov. and
M. malmesburii sp. nov., and M. tuberculosis/M. bovis. A 83.3%
sequence identity for this epitope was seen between each of M.
fortuitum and M. nonchromogenicum, and M. tuberculosis/M.
bovis.
PPE68 (Rv3873)
Alignment of the corresponding amino acid sequences of ppe68
orthologs of the NTM,M. bovis, andM. tuberculosis is illustrated
in Figure 10. The immunodominant M. tuberculosis epitope
“VLTATNFFGINTIPIALTEMDYFIR” described by Mustafa
(2014) was also found in M. fortuitum, M. komanii, and M.
nonchromogenicum showing 18/25 (72%) of the amino acid
residues to be identical between the NTM and M. tuberculosis.
M. smegmatis showed 19/25 (76%) amino acid sequence identity
of this region to that ofM. tuberculosis.
Identification of Proteins Present in the
PPD Preparations
Using Mass spectrometry, 608 different proteins were identified
in all the PPD preparations combined (consensus from the
different analysis) (Supplementary data). One hundred and thirty
two were identified in PPD-B. Among the NTM PPDs, PPD-
A showed the highest number of proteins (n = 225) followed
by PPD-F (n = 193), PPD-N (n = 189), and PPD-M (n =
136) while 39 proteins were identified in PPD-K. The molecular
mass of the majority of the proteins was found to be in the
range of 10–50 kDA. Twenty two proteins were identified
as shared between the NTM PPD preparations and PPD-B
Frontiers in Microbiology | www.frontiersin.org 15 June 2016 | Volume 7 | Article 795
Gcebe et al. Genomics and Proteomics of Four NTM
FIGURE 10 | Continued
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FIGURE 10 | Alignment of PPE68 aa sequences of M. fortuitum ATCC 6841 (M. fortuit), M. smegmatis MC2 155 (M. smegmat), M. nonchromogenicum
(M. nonchro), M. komanii sp. nov.,M. bovis, andM. tuberculosis (M. tubercu). *Indicates identical aa sequences in all species, and >indicates same aa residue
in at least one of the NTM species and M. bovis/M. tuberculosis. Highly immunogenic epitope of M. tuberculosis, as described by Mustafa (2014) are Underlined.
(Table 7). Identities and functions of these proteins are also listed
in Supplementary Table 8. These proteins include previously
characterized immunodominant MTBC proteins like: the 10 kDa
culture filtrate protein/CFP-10 (shared between PPD-B and PPD-
M); the 10 kDa chaperonin GroES (shared between the NTM
PPDs except PPD-M, and PPD-B); 60 kDa chaperonin GroEL
(shared by all the NTM PPDs and PPD-B); Chaperone protein
DNAK (shared by all the NTM PPDs and PPD-B); Secreted
antigen Ag85C (shared between PPD-A and PPD-B), 6 kDa early
secretory antigenic target/ESAT-6 (shared between PPD-K and
PPD-B) and EsxN (shared between PPD-K and PPD-B). The
Venn diagrams in Figure 11 illustrate the number of shared
proteins between PPD-B, PPD-A and different NTM PPDs, as
well as unique proteins of each PPD. There was a higher degree
of protein overlap between PPD-A and PPD-B (16/22 shared
proteins) than between the other NTM PPDs and PPD-B. Eight
proteins were shared between PPD-B and each of the following
NTM PPDs: PPD-M, PPD- while 11 proteins were shared
between PPD-B and PPD-K and 10 between PPD-B and PPD-N.
One hundred and ten proteins were identified as unique to PPD-
B. Four hundred and seventy seven proteins were identified as
unique to NTM. Some of the proteins detected only in NTM
PPDs have been previously characterized as immunogenic in M.
bovis/M. tuberculosis and were also in the NTM database entries.
These include most notably: M. fortuitum MPB63 (identified in
PPD-F and PPD-N), M. fortuitum Ag85C (identified in PPD-F,
PPD-M, and PPD-N), M. fortuitum Ag85A (identified in PPD-F
and PPD-N),M. kansasiiAg85B (identified in PPD-K),M. avium
MPB64 (identified in PPD-A),M. aviumAg85A andAg85B (both
identified in PPD-A).
DISCUSSION
In this study we first compared whole genome sequences of
four NTM species to those of M. tuberculosis and M. bovis,
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mainly focusing on the presence in NTM of genes homologous
to those encoding immunogenic proteins of the Esx and the
PE/PPE families in M. bovis/M. tuberculosis. As a second
approach, comparative proteomic analysis of PPDs derived from
four NTM species to those of commercially available PPDs of
M. bovis and M. avium–was conducted to identify the actual
presence of homologous proteins. Three of the investigated
NTM species i.e M. nonchromogenicum, M. malmesburii sp.
nov., and M. komanii sp. nov. had previously been described
as being among the most abundant NTM in cattle, buffalo
and the environments of these animals in South Africa. M.
fortuitum ATCC 6841 and its PPD was chosen because it is
currently used in the modified BOVIGAMTM assay (Michel
et al., 2011; Gcebe et al., 2013). M. malmesburii sp. nov and M.
komanii sp. nov. strains used in this study were both isolated
from cattle nose mucous membranes andM. nonchromogenicum
from soil in South Africa (Gcebe et al., 2013). M. malmesburii
sp. nov. and M. komanii sp. nov. are novel rapidly growing
mycobacteria (RGM) (colonies taking<7 days to appear on solid
medium).M. nonchromogenicum (a slow growing mycobacterial
(SGM) species (colonies take >7 days to appear on solid growth
medium) and M. fortuitum (a RGM) have also been isolated
from cattle tissue in Great Britain, France, and Northern Ireland
(Pollock and Anderson, 1997; Hughes et al., 2005; Vordermeier
et al., 2007; Biet and Boschiroli, 2014) These two species were
also reported to be among the most frequently isolated NTM in
cattle in other parts of Africa (Diguimbaye-Djaibé et al., 2006;
Berg et al., 2009). Exposure of cattle to these NTM species may
constitute a possible cause of cross-reactive immune response
to PPD and may lead to misdiagnosis of BTB. This further
highlighted the need to investigate these NTM in much more
detail in terms of their genetic make-up as well as the proteomes
of their PPDs in order to assess the presence of immunogenic
proteins in NTM potentially causing cross-reactivity with MTBC
antigens. Comparative genomics revealed that overall there was
very little similarity between the NTM genomes and those of M.
bovis and M. tuberculosis. Despite these differences, orthologs
of genes encoding for the most investigated antigens of the
Esx family of MTBC including EsxA/ESAT-6, EsxB/CFP-10,
EsxH/TB10.4, EsxG/TB 9.8 and EsxN; and the PE/PPE family
proteins (PE35, PE5 and PPE68) were identified in the four newly
sequenced NTM (Skjøt et al., 2000; Vordermeier et al., 2007; Zvi
et al., 2008; Hoang et al., 2013; Amoudy et al., 2014; Mustafa,
2014). Only ESX-1, ESX-3, and ESX-4 loci were detected in the
newly sequenced RGM, while genes of ESX-2 as well as esxN of
ESX-5 were also identified in M. nonchromogenicum by whole
genome analysis. The presence of esxA and esxB (situated within
the ESX-1 locus) were confirmed in M. fortuitum by PCR and
sequencing, while esxN (situated in ESX-5 locus) was confirmed
in M. nonchromogenicum also by PCR and sequencing. The
esxA and esxB could not be amplified in M. nonchromogenicum,
M. malmesburii sp. nov., and M. komanii sp. nov. using M.
tuberculosis/M. bovis (result not shown) as well as M. smegmatis
primers, probably due to huge nucleotide sequence differences
between these species. The esxH gene (situated in ESX-3 locus)
was also confirmed by PCR and sequencing in three of the
NTM except M. nonchromogenicum using M. smegmatis derived
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FIGURE 11 | Venn diagrams illustrating overlap of proteins identified
among (A) PPDA-PPD-B, PPD-F, (B) PPD-A, PPD-B, PPD-K, (C) PPD-A,
PPD-B, PPD-M, (D) PPD-A, PPD-B, and PPD-N.
primers. This was possibly due to little homology between the
M. nonchromogenicum esxH sequence and that ofM. smegmatis,
for these primers to anneal. The esxA, esxB, and esxH genes
were however, identified in all the four NTM genomes by whole
genome sequence analysis.
Studies have shown that the esx genes like esxA and esxB
as well as esxG and esxH interact to form a 1:1 heterodimer
which may be essential for their secretion (Uplekar et al., 2011).
Likewise the pe and ppe genes are thought to form pairs (Gey
van Pittius et al., 2006; Uplekar et al., 2011). In this study the
esxA and esxB; esxG and esxH; pe35 and ppe68 genes were
found to occur next to each other in the genomes of the four
newly sequenced NTM. This confirmed that esxA, esxB, esxG,
esxH, pe35, and ppe68 genes in these loci were true orthologs
of M. tuberculosis and M. bovis esx, pe, and ppe genes. A
closer inspection of the genes adjacent to the esx, pe, and ppe
genes situated within the ESX-loci revealed the occurrence of
orthologs of genes encoding for the ATP- dependent chaperones
of the AAA family, membrane bound ATPAses, transmembrane
proteins chaperonin, and mycosin- subtilin like proteins. These
genes form part of the type VII secretory system, therefore if
expressed in these NTM, the Esx, PE, and PPE proteins may be
secreted.
In NTM; ESAT-6, CFP-10, TB10.4, PE35, PE5, and PPE68
antigens of M. bovis and M. tuberculosis have been mainly
shown to cross-react with homologs of other pathogenic
Mycobacterium species that are phylogenetically closely related
to MTBC including M. kansasii, M, marinum, M. ulcerans,
as well as in M. leprae (Geluk et al., 2002, 2004; Skjøt et al.,
2002; Vordermeier et al., 2007; Amoudy et al., 2014; Mustafa,
2014). Identification of the genes of the Esx family and the
PE/PPE family proteins in nonpathogenic NTM in this study
add to earlier reports of their occurrence in nonpathogenic
M. smegmatis, Mycobacterium sp. MCS, Mycobacterium sp.
JLS, Mycobacterium phlei, Mycobacterium thermoresistible,
Mycobacterium gilvum PYR-GCK, Mycobacterium vaccae,
Mycobacterium vanbaalenii, and Mycobacterium sp. KMS (Gey
van Pittius et al., 2006; Newton-Foot et al., 2016). Expression
of the proteins of the Esx family, the PE/PPE family as well
as the other antigens in nonpathogenic NTM have not been
investigated. For that reason we did comparative investigation
for the presence of these proteins in PPDs of three of the
nonpathogenic NTM: M. fortuitum (PPD-F), M. malmesburii
sp. nov. (PPD-M) and M. nonchromogenicum (PPD-M) and
in addition M. kansasii (PPD-K) compared to M. bovis (PPD-
B) and M. avium (PPD-A) by Mass Spectrometric analysis.
Mycobacterium kansasii derived PPD was included in this study,
since its antigens have been investigated for their cross reactivity
with M. bovis (Vordermeier et al., 2007). This bacterium has
been isolated from cattle in Great Britain and the United States
of America (Vordermeier et al., 2007; Thacker et al., 2013). Even
though proteins are largely degraded during PPD preparation,
we identified as many as 609 proteins in the combined six
PPDs and we found 22 of these proteins to be shared between
PPD-B and one or more of the NTM PPDs, including PPD-A.
In the different NTM PPDs we identified homologs of some
of previously characterized immunogenic MTBC proteins
including CFP-10 (present in PPD-M), GroES (present in all
PPDs except PPD-M), GroEL (present in all PPDs), EsxN (PPD-
K), ESAT-6 (PPD-K), and DnaK (all PPDs except PPD-M). The
occurrence of these immunogenic antigens in nonpathogenic
RGM PPDs could potentially lead to cross-reactive immune
responses that may interfere with the diagnosis of bovine
tuberculosis. In fact these proteins may be responsible for
cross-reactivity seen between theM. fortuitum PPD andM. bovis
PPD in South Africa (Michel et al., 2011).
In an attempt to predict cross-reactivity of the NTM
homologs of ESAT-6, CFP-10, EsxH, and PPE68 more precisely,
we compared amino acid sequences in these proteins with
those of defined immunogenic epitopes in the proteins of
M. bovis and M. tuberculosis (Skjøt et al., 2000; Vordermeier
et al., 2003, 2007; Mustafa, 2014). This was done despite the
fact that some of the genes encoding for these proteins were
identified at DNA level, but not represented as proteins in the
respective NTM PPD preparations. These proteins, with the
exception of M. malmesburii sp. nov.’s CFP-10 which was found
in PPD-M, could have been degraded during PPD preparation,
and possibly differential sensitivity for procedures of PPD
production and trypsin treatment before Mass spectrometry
or were not abundantly expressed in NTM to allow detection
by LC-MS/MS (Borsuk et al., 2009). In all cases as illustrated
in the amino acid alignments in Figures 6–10, homologies of
>50% of the previously characterized immunogenic epitopes
in M. bovis were seen in the different NTM homologs. For
instance, six epitopes of M. bovis ESAT-6 recognized by bovine
T-cells in the context of BoLA-DR and BoLA DQ, as described
by Vordermeier et al. (2003, 2007) had amino acid sequence
homologies of as high as 81.28% and as low as 52.9% to those
of the M. fortuitum and M. nonchromogenicum orthologs.
Likewise amino acid sequence homologies of >50% between
the four M. bovis CFP-10 immunogenic epitopes and those of
the NTM species was observed. The same was seen with PPE68
immunogenic epitope (VLTATNFFGINTIPIALTEMDYFIR)
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described by Mustafa (2014) where 72% of the amino acid
residues were identical between the NTM and M. tuberculosis.
Still with the sequence homology of <100% of the NTM CFP-10,
ESAT-6, PPE68, and EsxH epitopes and the M. bovis antigens,
we could not unambiguously predicts T- cell cross reactivity.
Several studies have reported contrasting results with regards to
the relation of sequence identity and cross-reactivity of antigens.
For instance, antigen cross-recognition has been observed with
M. leprae ESAT-6 and CFP-10 onM. tuberculosis patients despite
very low sequence identity (36 and 40% respectively at amino
acid level) to the M. tuberculosis homologs (Geluk et al., 2002,
2004). Likewise, Hewinson et al. (2006) also demonstrated that
sequence identity between epitopic regions from unrelated
otherwise non-homologous mycobacterial antigens of >50%
in the 16–20 mer regions indicated cross-reactivity in cattle
(Hewinson et al., 2006). Contrary, other peptides that displayed
similar degrees of sequence identity were not cross-reactive
(Hewinson et al., 2006).
The NTM homologs in this study could potentially induce
cross reactivity against MTBC antigens and should be tested in
animal experiments.
In conclusion, in this study we identified genes and proteins
present in and expressed by members of the Mycobacterium
tuberculosis complex known as markers for BTB diagnosis in
selected nonpathogenic NTM genomes and proteomes. The
identification of the genes encoding ESAT-6, CFP-10, PE35,
PPE68, and PE5 in nonpathogenic NTM in this study adds
to earlier findings of these genes in nonpathogenic like M.
smegmatis and Mycobacterium sp. KMS. Expression of one
of the most studied M. bovis immunogenic proteins, CFP-
10 in M. malmesburii sp. nov. and that of other previously
characterized MTBC immunogenic proteins such as GroES,
DnaK, GroEL was shown by mass spectrometric analysis of the
PPDs.We also identified immunogenic epitopes of ESAT-6, CFP-
10, EsxH, and PPE68 through genomic analysis, in some or all of
the four newly sequenced nonpathogenic NTM, also suggesting
the potential of these proteins, to elicit cross reactive immune
responses against MTBC antigens. The NTM homologs of the
immunogenic proteins need to be further investigated for their
cross-reactivity with theM. bovis antigens and consequently their
interference in BTB assays.
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